AIM - AIM ImmunoTech Inc.
0.6908
-0.009 -1.332%
Share volume: 161,205
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$0.70
-0.01
-0.01%
View ratios
| Fiscal Date | 12-31-2024 | 06-30-2025 | 09-30-2025 | |
|---|---|---|---|---|
| Fiscal Quarter | Q4 2024 | Q2 2025 | Q3 2025 | |
| Report Date | 03-27-2025 | 08-14-2025 | 11-17-2025 | |
| Cash flow financing | 1.037 M | 355.000 K | 6.654 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | |
| Cash flow | 786.000 K | -422.000 K | 1.871 M | |
| Net income | -5.967 M | -2.794 M | -3.284 M | |
| Depreciation | 9.000 K | 9.000 K | 9.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 3.704 M | 754.000 K | 296.000 K | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | |
| Cash Change | 786.000 K | -422.000 K | 1.871 M |